Should You Add Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock to Your Portfolio Friday?

A rating of 72 puts Sonnet BioTherapeutics Holdings, Inc. (SONN) near the top of the Healthcare sector according to InvestorsObserver. Sonnet BioTherapeutics Holdings, Inc.'s score of 72 means that it ranks higher than 72% of stocks in the sector. In addition, its overall score of 34 ranks it higher than 34% of all stocks.

SONN has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on SONN!

See Full SONN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Sonnet BioTherapeutics Holdings, Inc. Stock Today?

Sonnet BioTherapeutics Holdings, Inc. (SONN) stock is trading at $1.31 as of 10:15 AM on Friday, Nov 3, a rise of $0.01, or 0.77% from the previous closing price of $1.30. The stock has traded between $1.28 and $1.34 so far today. Volume today is light. So far 13,104 shares have traded compared to average volume of 65,334 shares. Click Here to get the full Stock Report for Sonnet BioTherapeutics Holdings, Inc. stock.